Association of Health Care Journalists, September 18, 2024: AHCJ questions the usefulness of FDA’s new active monitoring system to improve medical device safety and NCHR and other experts do too. The FDA plans to start by monitoring two types of devices in the first year but there are thousands of devices that were never studied for safety or effectiveness so that is not going to keep patients safe anytime soon.
Read More »News That Quotes Us & Our Work
We are often quoted in major newspapers and magazines, and on well-respected TV shows, radio programs, and websites where we share our opinion on issues that matter to you and your health. Stay up to date on health news and our take on it by reading the articles in this section.
The untold trauma of thousands of women suffering from ‘Breast Implant Illness’, leaving them in agony for years… yet some doctors refuse to accept it is real
The Daily Mail, September 9, 2024: After making the decision to decrease her cancer risk by removing her breasts and getting implants, one woman discovered a community of women suffering from breast implant illness. Celebrities describe similar health problems from implants and recovery after implants are removed. Despite popularity of explant surgery and mounting evidence of BII, many doctors continue to dismiss breast implant illness, leaving women dependent on online support groups for information. FDA has not ensured accurate information for patients.
Read More »He Regulated Medical Devices. His Wife Represented Their Makers.
The New York Times, August 20, 2024: Ever wonder why there are so many ineffective and unsafe implants and diagnostic tests and other medical devices harming patients? This NYT investigation explains how FDA official Jeff Shuren was involved in decisions that benefited his wife — who worked for Theranos and other major device companies. Why did FDA allow that to happen year after year?
Read More »Jeff Shuren stabilized the FDA’s medical devices center, winning over industry but not all patients
STAT News, August 6, 2024: STAT News article on Jeff Shuren leaving the FDA quotes praise from industry and concerns from physicians, researchers, patients, and public health experts who criticize how many devices are not proven to work.
Read More »How Good Is Wegovy’s Heart Benefit? — Experts put SELECT trial findings in context
MedPage Today, August 1, 2024: When the company that makes Wegovy weight loss drugs say it reduces major cardiovascular events by 20% they really mean it reduces that risk by 1.5% for each patient. That’s because only 8% of the placebo group had major cardiovascular events, compared to 6.5% of the Wegovy patients. Isn’t that misleading? We explain why most weight loss patients will not benefit in terms of heart disease, because the benefit is small and requires staying on Wegovy for almost 3 years.
Read More »